Welcome to our dedicated page for Hno International SEC filings (Ticker: HNOI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HNO International, Inc. filings document material agreements and capital-structure transactions for a Nevada corporation developing hydrogen-based energy technologies. Recent Form 8-K disclosures cover convertible promissory notes, common stock purchase warrants, an equity purchase agreement, promissory note extensions, and related placement-agent arrangements.
The company’s regulatory filings also record changes in its independent accountant, late-filing notifications on Form 12b-25, common-stock issuance mechanics, beneficial ownership limits, share reserve obligations, maturity dates, conversion terms, and going-concern language included in audit reporting. These documents provide formal disclosure around financing activity, reporting status, governance matters and risk-related accounting disclosures.
HNO International, Inc. filed a notification that its Annual Report on Form 10-K for the year ended October 31, 2025 will be late. The company cites a delay in obtaining and compiling information for the Form 10-K that could not be resolved without unreasonable effort and expense.
HNO International states it will file the Form 10-K no later than the fifteenth calendar day after the original due date, as permitted under Rule 12b-25. The company also indicates all other required periodic reports over the past 12 months have been filed and that it does not expect any significant change in results of operations compared with the prior fiscal year.
HNO International, Inc. reported that on December 29, 2025 it entered into nine separate extensions of existing promissory notes with its affiliate HNO Green Fuels, Inc., all documented as Extension to Promissory Note agreements. Each extension amends a note originally issued between December 1, 2021 and April 17, 2023, and in every case the maturity date is pushed back from December 31, 2025 to December 31, 2026. The company has filed each extension as an exhibit to the report, indicating these related-party debt arrangements will now come due one year later than previously scheduled.
HNO International CEO Donald W. Owens reported a disposition of 450,000 shares of common stock on 11/26/2025. The transaction was recorded with transaction code "G" at a reported price of $0.00 per share. After this change, Owens beneficially owned 29,550,000 shares of HNO International common stock in direct ownership. He is identified as a director, a 10% owner, and an officer of the company, serving as CEO, President, and Secretary.
HNO International, Inc. (HNOI) reported interim 10-Q information showing a small asset base and substantial related-party support while recording material equity transactions and restatements. The balance sheet shows property and equipment, net of $1,399,793 and operating lease liabilities totaling $80,668 (current $59,966; non‑current $20,702). Current liabilities include accounts payable $407,737, accrued interest payable $49,414 and advances from related parties $1,091,585. The company recorded a $60,000 convertible note at fair value and significant stock transactions during the period, including Regulation D/A sales raising cash (examples: $527,500 and $394,000) and stock issued for services (e.g., stock‑based compensation of $5,092,557 and $241,380). The filing discloses a going concern statement and management plans to raise additional capital. Several prior-period adjustments and cancellations of preferred/common shares and a termination of a patent agreement are disclosed.
HNO International, Inc. (HNOI) reported interim 10-Q information showing a small asset base and substantial related-party support while recording material equity transactions and restatements. The balance sheet shows property and equipment, net of $1,399,793 and operating lease liabilities totaling $80,668 (current $59,966; non‑current $20,702). Current liabilities include accounts payable $407,737, accrued interest payable $49,414 and advances from related parties $1,091,585. The company recorded a $60,000 convertible note at fair value and significant stock transactions during the period, including Regulation D/A sales raising cash (examples: $527,500 and $394,000) and stock issued for services (e.g., stock‑based compensation of $5,092,557 and $241,380). The filing discloses a going concern statement and management plans to raise additional capital. Several prior-period adjustments and cancellations of preferred/common shares and a termination of a patent agreement are disclosed.
HNO International, Inc. filed Amendment No.1 to its quarterly report to correct the valuation applied to service stock issuances. The revised stock price valuation increased stock-based compensation expense by $4,827,055 for the six months ended April 30, 2025; this non-cash adjustment increased additional paid-in capital and adjusted accumulated deficit.
The restatement also reflects cancellation of 5,000,000 Series A preferred shares, recognition of stock issuances including 16,125,000 common shares valued at $5,092,557 for services, and a convertible note issued for legal services recorded at fair value of $59,985 (resulting in a $14,985 loss). The Company reports material related-party advances (current advances of $1,319,585) and states it has not generated sufficient operating cash flow and will need to raise additional funds to continue operations. Subsequent to period end, the Company issued 3,700,000 common shares for $185,000 for working capital.
HNO International, Inc. filed Amendment No.1 to its quarterly report to correct the valuation applied to service stock issuances. The revised stock price valuation increased stock-based compensation expense by $4,827,055 for the six months ended April 30, 2025; this non-cash adjustment increased additional paid-in capital and adjusted accumulated deficit.
The restatement also reflects cancellation of 5,000,000 Series A preferred shares, recognition of stock issuances including 16,125,000 common shares valued at $5,092,557 for services, and a convertible note issued for legal services recorded at fair value of $59,985 (resulting in a $14,985 loss). The Company reports material related-party advances (current advances of $1,319,585) and states it has not generated sufficient operating cash flow and will need to raise additional funds to continue operations. Subsequent to period end, the Company issued 3,700,000 common shares for $185,000 for working capital.
HNO International, Inc. filed Amendment No.1 to its quarterly report to correct the valuation applied to service stock issuances. The revised stock price valuation increased stock-based compensation expense by $4,827,055 for the six months ended April 30, 2025; this non-cash adjustment increased additional paid-in capital and adjusted accumulated deficit.
The restatement also reflects cancellation of 5,000,000 Series A preferred shares, recognition of stock issuances including 16,125,000 common shares valued at $5,092,557 for services, and a convertible note issued for legal services recorded at fair value of $59,985 (resulting in a $14,985 loss). The Company reports material related-party advances (current advances of $1,319,585) and states it has not generated sufficient operating cash flow and will need to raise additional funds to continue operations. Subsequent to period end, the Company issued 3,700,000 common shares for $185,000 for working capital.
HNO International, Inc. filed Amendment No.1 to its quarterly report to correct the valuation applied to service stock issuances. The revised stock price valuation increased stock-based compensation expense by $4,827,055 for the six months ended April 30, 2025; this non-cash adjustment increased additional paid-in capital and adjusted accumulated deficit.
The restatement also reflects cancellation of 5,000,000 Series A preferred shares, recognition of stock issuances including 16,125,000 common shares valued at $5,092,557 for services, and a convertible note issued for legal services recorded at fair value of $59,985 (resulting in a $14,985 loss). The Company reports material related-party advances (current advances of $1,319,585) and states it has not generated sufficient operating cash flow and will need to raise additional funds to continue operations. Subsequent to period end, the Company issued 3,700,000 common shares for $185,000 for working capital.
HNO International, Inc. filed Amendment No.1 to its Quarterly Report for the quarter ended January 31, 2025, to correct the valuation applied to service stock issuances. The correction increased stock-based compensation expense by $4,827,055, a non-cash adjustment that also increased additional paid-in capital and adjusted accumulated deficit.
The amendment restates notes to the financial statements and MD&A only; no other changes were made to the originally filed report. The filing discloses extensive equity activity, including issuance and cancellation of preferred and common shares, and detailed related-party notes and settlements. The company also reiterates a going concern disclosure, stating it has not generated sufficient operating cash and will need additional financing or other arrangements to continue operations.
HNO International, Inc. filed Amendment No.1 to its Quarterly Report for the quarter ended January 31, 2025, to correct the valuation applied to service stock issuances. The correction increased stock-based compensation expense by $4,827,055, a non-cash adjustment that also increased additional paid-in capital and adjusted accumulated deficit.
The amendment restates notes to the financial statements and MD&A only; no other changes were made to the originally filed report. The filing discloses extensive equity activity, including issuance and cancellation of preferred and common shares, and detailed related-party notes and settlements. The company also reiterates a going concern disclosure, stating it has not generated sufficient operating cash and will need additional financing or other arrangements to continue operations.
HNO International, Inc. filed Amendment No.1 to its Quarterly Report for the quarter ended January 31, 2025, to correct the valuation applied to service stock issuances. The correction increased stock-based compensation expense by $4,827,055, a non-cash adjustment that also increased additional paid-in capital and adjusted accumulated deficit.
The amendment restates notes to the financial statements and MD&A only; no other changes were made to the originally filed report. The filing discloses extensive equity activity, including issuance and cancellation of preferred and common shares, and detailed related-party notes and settlements. The company also reiterates a going concern disclosure, stating it has not generated sufficient operating cash and will need additional financing or other arrangements to continue operations.
HNO International, Inc. filed Amendment No.1 to its Quarterly Report for the quarter ended January 31, 2025, to correct the valuation applied to service stock issuances. The correction increased stock-based compensation expense by $4,827,055, a non-cash adjustment that also increased additional paid-in capital and adjusted accumulated deficit.
The amendment restates notes to the financial statements and MD&A only; no other changes were made to the originally filed report. The filing discloses extensive equity activity, including issuance and cancellation of preferred and common shares, and detailed related-party notes and settlements. The company also reiterates a going concern disclosure, stating it has not generated sufficient operating cash and will need additional financing or other arrangements to continue operations.
HNO International, Inc. filed Amendment No.1 to its Quarterly Report for the quarter ended January 31, 2025, to correct the valuation applied to service stock issuances. The correction increased stock-based compensation expense by $4,827,055, a non-cash adjustment that also increased additional paid-in capital and adjusted accumulated deficit.
The amendment restates notes to the financial statements and MD&A only; no other changes were made to the originally filed report. The filing discloses extensive equity activity, including issuance and cancellation of preferred and common shares, and detailed related-party notes and settlements. The company also reiterates a going concern disclosure, stating it has not generated sufficient operating cash and will need additional financing or other arrangements to continue operations.
HNO International, Inc. filed a 10-K/A correcting prior year equity valuations and related disclosures. The company revised the valuation of service stock issuances from $0.001 to $0.23, which increased stock-based compensation expense by $1,108,368 and produced corresponding increases to additional paid-in capital and an adjustment to accumulated deficit. The amendment reverses an $82,500 intangible asset and $3,176 of related amortization following termination of a Patent Purchase Agreement and cancellation of 5,000,000 Series A preferred shares. The restatement reclassifies $21,560 of expenses to accounts payable and records the settlement of a $56,392 related‑party receivable through transferred equipment. The filing includes a going concern disclosure and restated 2023 net loss of $1,927,494, additional paid-in capital of $41,470,177, and an accumulated deficit of $(42,096,104).
HNO International, Inc. filed a 10-K/A correcting prior year equity valuations and related disclosures. The company revised the valuation of service stock issuances from $0.001 to $0.23, which increased stock-based compensation expense by $1,108,368 and produced corresponding increases to additional paid-in capital and an adjustment to accumulated deficit. The amendment reverses an $82,500 intangible asset and $3,176 of related amortization following termination of a Patent Purchase Agreement and cancellation of 5,000,000 Series A preferred shares. The restatement reclassifies $21,560 of expenses to accounts payable and records the settlement of a $56,392 related‑party receivable through transferred equipment. The filing includes a going concern disclosure and restated 2023 net loss of $1,927,494, additional paid-in capital of $41,470,177, and an accumulated deficit of $(42,096,104).
HNO International, Inc. filed a 10-K/A correcting prior year equity valuations and related disclosures. The company revised the valuation of service stock issuances from $0.001 to $0.23, which increased stock-based compensation expense by $1,108,368 and produced corresponding increases to additional paid-in capital and an adjustment to accumulated deficit. The amendment reverses an $82,500 intangible asset and $3,176 of related amortization following termination of a Patent Purchase Agreement and cancellation of 5,000,000 Series A preferred shares. The restatement reclassifies $21,560 of expenses to accounts payable and records the settlement of a $56,392 related‑party receivable through transferred equipment. The filing includes a going concern disclosure and restated 2023 net loss of $1,927,494, additional paid-in capital of $41,470,177, and an accumulated deficit of $(42,096,104).
HNO International, Inc. filed a 10-K/A correcting prior year equity valuations and related disclosures. The company revised the valuation of service stock issuances from $0.001 to $0.23, which increased stock-based compensation expense by $1,108,368 and produced corresponding increases to additional paid-in capital and an adjustment to accumulated deficit. The amendment reverses an $82,500 intangible asset and $3,176 of related amortization following termination of a Patent Purchase Agreement and cancellation of 5,000,000 Series A preferred shares. The restatement reclassifies $21,560 of expenses to accounts payable and records the settlement of a $56,392 related‑party receivable through transferred equipment. The filing includes a going concern disclosure and restated 2023 net loss of $1,927,494, additional paid-in capital of $41,470,177, and an accumulated deficit of $(42,096,104).
HNO International, Inc. (HNOI) disclosed that its Board, after consulting management, concluded prior financial statements for the fiscal year ended October 31, 2024 and the interim periods ended January 31, 2025 and April 30, 2025 should no longer be relied upon due to errors in valuing service stock issuances and related stock-based compensation. The corrected valuation increases stock-based compensation expense by $1,108,368 for the fiscal year ended October 31, 2024 and by $4,827,055 for the quarter ended January 31, 2025, with the January adjustment carrying into the quarter ended April 30, 2025.
The company says these are non-cash adjustments that also increase additional paid-in capital and adjust accumulated deficit. HNOI intends to file Amendment No. 2 to its Annual Report for the fiscal year ended October 31, 2024 and Amendment No. 1 to its Quarterly Reports for the quarters ended January 31, 2025 and April 30, 2025, and management has discussed the matters with its independent registered public accounting firm.
HNO International, Inc. (HNOI) disclosed that its Board, after consulting management, concluded prior financial statements for the fiscal year ended October 31, 2024 and the interim periods ended January 31, 2025 and April 30, 2025 should no longer be relied upon due to errors in valuing service stock issuances and related stock-based compensation. The corrected valuation increases stock-based compensation expense by $1,108,368 for the fiscal year ended October 31, 2024 and by $4,827,055 for the quarter ended January 31, 2025, with the January adjustment carrying into the quarter ended April 30, 2025.
The company says these are non-cash adjustments that also increase additional paid-in capital and adjust accumulated deficit. HNOI intends to file Amendment No. 2 to its Annual Report for the fiscal year ended October 31, 2024 and Amendment No. 1 to its Quarterly Reports for the quarters ended January 31, 2025 and April 30, 2025, and management has discussed the matters with its independent registered public accounting firm.